On 10 Jan 2012, the government of mainland China announced a joint effort by the Ministry of Health and State Food and Drug Administration (SFDA)
to better regulate stem cell treatments in a country that has become
notorious for its stem cell tourism. As part of the effort, all new
applications for clinical trials would be frozen until July.
Supposedly, health providers are forbidden to run clinics that charge
money for experimental stem cell treatments. It is questionable whether
the government health agencies can enforce this ban, as many of the
hospitals making money from stem cell tourism are affiliated with other
government organisations such as the army, the PLA, and the domestic
police forces. A similar order in 2009 was not enforced.
Reports: Bloomberg News, International Medical Travel Journal